Patton Albertson Miller Group, LLC Bristol Myers Squibb CO Transaction History

Patton Albertson Miller Group, LLC

$732 Million
Q4 2024

A detailed history of Patton Albertson Miller Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 4,750 shares of BMY stock, worth $284,762. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,750

Previous 4,750 -0.0%

Holding current value

$284,762

Previous $245,000 9.39%

% of portfolio

0.04%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $188,384 - $245,812	4,750 New	4,750 $245,000
Q1 2024 Apr 24, 2024	SELL	$47.98 - $54.4 $47,068 - $53,366	-981 Reduced 13.81%	6,120 $331,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $53,909 - $64,329	-1,112 Reduced 13.54%	7,101 $364,000
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $13,025 - $14,564	-225 Reduced 2.67%	8,213 $476,000
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $82,377 - $91,466	-1,293 Reduced 13.29%	8,438 $539,000
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $7,490 - $8,496	-114 Reduced 1.16%	9,731 $674,000
Q4 2022 Jan 23, 2023	SELL	$68.48 - $81.09 $10,956 - $12,974	-160 Reduced 1.6%	9,845 $0
Q3 2022 Oct 13, 2022	BUY	$0.13 - $76.84 $35 - $20,977	273 Added 2.81%	10,005 $711,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $11,473 - $12,636	-158 Reduced 1.6%	9,732 $749,000
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $43,650 - $52,341	-710 Reduced 6.7%	9,890 $722,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $34,323 - $40,012	-640 Reduced 5.69%	10,600 $661,000
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $157,983 - $185,057	2,670 Added 31.16%	11,240 $665,000
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $12,382 - $13,484	-200 Reduced 2.28%	8,570 $573,000
Q1 2021 Apr 21, 2021	SELL	$59.34 - $66.74 $3,857 - $4,338	-65 Reduced 0.74%	8,770 $554,000
Q4 2020 Feb 25, 2021	SELL	$57.74 - $65.43 $12,125 - $13,740	-210 Reduced 2.32%	8,835 $525,000
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $10,337 - $11,455	-180 Reduced 1.95%	9,045 $545,000
Q1 2020 May 22, 2020	SELL	$46.4 - $67.43 $22,225 - $32,298	-479 Reduced 4.94%	9,225 $514,000
Q4 2019 Feb 06, 2020	SELL	$49.21 - $64.19 $12,696 - $16,561	-258 Reduced 2.59%	9,704 $623,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $27,073 - $32,099	-633 Reduced 5.97%	9,962 $505,000
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $472,748 - $522,757	10,595 New	10,595 $501,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $59,048 - $76,571	-1,211 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$55.19 - $62.25 $66,835 - $75,384	1,211 New	1,211 $59,000

Others Institutions Holding BMY

# of Institutions

2,604

Shares Held

1.47B

Call Options Held

31.5M

Put Options Held

34.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $127B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.

Account

Patton Albertson Miller Group, LLC Bristol Myers Squibb CO Transaction History